Effects of L-Tyrosine and Caffeine on Performance in Elite Boxers

Официальное название

Effects of L-Tyrosine and Caffeine Supplementation on Cognitive, Physical, and Physiological Parameters in Elite Boxers: A Randomized Double-Blind Placebo-Controlled Crossover Study

Обзор

Participants will complete six sessions, including one familiarization and baseline session followed by five experimental conditions: control (no supplementation), placebo, L-tyrosine, caffeine, and combined L-tyrosine plus caffeine. The experimental conditions will be performed in a randomized, counterbalanced crossover design with a washout period of at least 72 hours between sessions. Resting physiological and cognitive assessments will be performed during the familiarization session, while biochemical, cognitive, and boxing-specific performance assessments will be conducted before and after each experimental session.

Подробное описание

Participants will attend six sessions in total. The first session will be used for familiarization and baseline assessments, including anthropometric measurements, resting physiological measurements, and cognitive performance testing. The remaining five sessions will consist of one control condition (no supplementation) and four randomized experimental conditions (placebo, L-tyrosine, caffeine, and combined L-tyrosine plus caffeine) administered in a randomized, counterbalanced crossover design.

Each experimental session will be separated by a washout period of at least 72 hours. During the placebo, L-tyrosine, caffeine, and combined supplementation conditions, the assigned intervention will be administered 60 minutes before exercise. No supplement will be administered during the control condition.

Before and immediately after each experimental session, venous blood samples will be collected to assess brain-derived neurotrophic factor (BDNF) and oxidative stress biomarkers, including total antioxidant status (TAS), total oxidant status (TOS), malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx). Cognitive performance will be evaluated using the computerized Stroop test, and boxing-specific physical performance will be assessed using a standardized boxing simulation protocol. Heart rate and rating of perceived exertion (RPE) will also be recorded during the exercise protocol.

Вмешательства

• Пищевая добавка Placebo
  Placebo solution matched in taste and volume to active supplements.
• Пищевая добавка L-Tyrosine
  L-tyrosine at 150 mg/kg body weight administered 60 minutes before exercise.
• Пищевая добавка Caffeine
  Caffeine at 5 mg/kg body weight administered 60 minutes before exercise.
• Пищевая добавка L-tyrosine + Caffeine
  Combined L-tyrosine (150 mg/kg) and caffeine (5 mg/kg) administered 60 minutes before exercise.

Первичные конечные точки

• Stroop Test Performance [Срок оценки: up to 12 weeks]

Вторичные конечные точки (2)

• BDNF Levels [Срок оценки: up to 12 weeks]
• Oxidative Stress Markers [Срок оценки: up to 12 weeks]

Критерии участия

Критерии включения

Male elite boxers aged ≥18 years At least 8 years of boxing training experience Active participation in national or international competitions Regular training schedule No injury or illness affecting performance

Критерии исключения

Use of nutritional supplements or stimulants within the last 4 weeks Any cardiovascular, metabolic, or neurological disorder Current injury or musculoskeletal limitation Smoking or excessive caffeine intake Failure to comply with study procedures

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение

Рандомизированное

Модель

Перекрёстный дизайн

Маскирование

Двойное слепое

Основная цель

Фундаментальное исследование

Центры проведения

Turkey (Türkiye) · 1 центр

• Ataturk University Faculty of Sport Sciences — Erzurum

Идентификаторы

NCT: NCT07530185 · UcarPhD2026

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗